Liraglutide Protects Stomach From NSAID-Induced Ulcer Damage

Liraglutide protected against indomethacin-induced gastric damage in a preclinical model, adding gastroprotection to GLP-1 drug benefits through anti-inflammatory mechanisms.

Arslan, Huseyin Emre et al.·Acta cirurgica brasileira·2025·Preliminary Evidenceanimal study
RPEP-09989Animal studyPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
animal study
Evidence
Preliminary Evidence
Sample
N=63
Participants
Male Wistar rats with streptozotocin-induced diabetes

What This Study Found

Liraglutide protected against indomethacin-induced gastric damage in a preclinical model, adding gastroprotection to GLP-1 drug benefits through anti-inflammatory mechanisms.

Key Numbers

63 male Wistar rats in 7 groups. STZ for diabetes induction. Indomethacin for ulcer induction. Liraglutide at 0.2 mg/kg and 0.4 mg/kg. Compared to omeprazole.

How They Did This

In publication.

Why This Research Matters

Relevant to peptide therapeutics.

The Bigger Picture

Advances peptide evidence.

What This Study Doesn't Tell Us

In publication.

Questions This Raises

  • ?Long-term implications?
  • ?Evidence comparison?
  • ?Next steps?

Trust & Context

Key Stat:
Key finding Liraglutide protected against indomethacin-induced gastric damage in a preclinical model, adding gas
Evidence Grade:
Based on design.
Study Age:
Published in 2025.
Original Title:
The effect of liraglutide, a GLP-1 analog, on indomethacin-induced gastric ulcers in diabetic rats.
Published In:
Acta cirurgica brasileira, 40, e407325 (2025)
Database ID:
RPEP-09989

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What does this mean?

Liraglutide protected against indomethacin-induced gastric damage in a preclinical model, adding gastroprotection to GLP-1 drug benefits through anti-inflammatory mechanisms.

How reliable?

Consult publication.

Read More on RethinkPeptides

Cite This Study

RPEP-09989·https://rethinkpeptides.com/research/RPEP-09989

APA

Arslan, Huseyin Emre; Teksen, Yasemin; Ozatik, Orhan; Algin, Mustafa Cem. (2025). The effect of liraglutide, a GLP-1 analog, on indomethacin-induced gastric ulcers in diabetic rats.. Acta cirurgica brasileira, 40, e407325. https://doi.org/10.1590/acb407325

MLA

Arslan, Huseyin Emre, et al. "The effect of liraglutide, a GLP-1 analog, on indomethacin-induced gastric ulcers in diabetic rats.." Acta cirurgica brasileira, 2025. https://doi.org/10.1590/acb407325

RethinkPeptides

RethinkPeptides Research Database. "The effect of liraglutide, a GLP-1 analog, on indomethacin-i..." RPEP-09989. Retrieved from https://rethinkpeptides.com/research/arslan-2025-the-effect-of-liraglutide

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.